Virginia Casadei
Overview
Explore the profile of Virginia Casadei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
116
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Coltelli L, Allegrini G, Orlandi P, Finale C, Fontana A, Masini L, et al.
NPJ Breast Cancer
. 2022 Mar;
8(1):33.
PMID: 35314692
To investigate pharmacogenetic interactions among VEGF-A, VEGFR-2, IL-8, HIF-1α, EPAS-1, and TSP-1 SNPs and their role on progression-free survival (PFS) in metastatic breast cancer (MBC) patients treated with bevacizumab plus...
2.
Fiorentini G, Sarti D, Casadei V, Milandri C, Dentico P, Mambrini A, et al.
Integr Cancer Ther
. 2019 Sep;
18:1534735419878505.
PMID: 31561722
Pancreatic adenocarcinoma has a poor prognosis, resulting in a <10% survival rate at 5 years. Modulated electro-hyperthermia (mEHT) has been increasingly used for pancreatic cancer palliative care and therapy. To...
3.
Fiorentini G, Sarti D, Milandri C, Dentico P, Mambrini A, Fiorentini C, et al.
Integr Cancer Ther
. 2018 Dec;
18:1534735418812691.
PMID: 30580645
Background: There are interesting studies on glioma therapy with modulated electrohyperthermia (mEHT), which combines heat therapy with an electric field. Clinical researchers not only found the mEHT method feasible for...
4.
Rossi D, Giordani P, Alessandroni P, Catalano V, Casadei V, Baldelli A, et al.
World J Oncol
. 2017 Nov;
3(1):39-41.
PMID: 29147277
In this case report we describe the case of a patient with multiple bone metastases of NSCLC, adenocarcinoma with exon 21 point-mutation of EGFR, treated with gefitinib. After only 3...
5.
Allegrini G, Coltelli L, Orlandi P, Fontana A, Camerini A, Ferro A, et al.
Pharmacogenomics
. 2014 Dec;
15(16):1985-99.
PMID: 25521357
Aim: To investigate pharmacogenetic interactions among VEGF-A, VEGFR-2, IL-8, HIF-1α, EPAS-1 and TSP-1 SNPs and their role on progression-free survival in a population of metastatic breast cancer patients treated with...
6.
Catalano V, Bisonni R, Graziano F, Giordani P, Alessandroni P, Baldelli A, et al.
Gastric Cancer
. 2012 Oct;
16(3):411-9.
PMID: 23065042
Background: Elderly patients are generally underrepresented in the study populations of combination chemotherapy trials. This study evaluates the efficacy and safety of a modified FOLFOX regimen in elderly patients with...
7.
Catalano V, Vincenzi B, Giordani P, Graziano F, Santini D, Baldelli A, et al.
Gastric Cancer
. 2012 Jan;
15(4):419-26.
PMID: 22237659
Background: The combination of docetaxel, cisplatin, and 5-fluorouracil (5-FU) has demonstrated a survival advantage over cisplatin and 5-FU, but with substantial hematological toxicity. We aimed to evaluate the efficacy and...
8.
Rossi D, Dennetta D, Ugolini M, Catalano V, Alessandroni P, Giordani P, et al.
Target Oncol
. 2010 Oct;
5(4):231-5.
PMID: 20890670
Erlotinib is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor. Efficacy of this drug was documented in the BR.21 trial showing that adenocarcinoma, female gender, Asian ethnicity and never-smoker...
9.
Rossi D, Baldelli A, Catalano V, Casadei V, Alessandroni P, Giordani P, et al.
Breast Cancer
. 2009 Sep;
19(3):275-7.
PMID: 19756926
Visceral metastases of breast cancer have been commonly treated with "aggressive" anthracyclines/taxanes-based chemotherapy. In contrast, this case report concerns an elderly patient with advanced breast cancer (pleural effusion, peritoneal carcinosis,...
10.
Rossi D, Dennetta D, Ugolini M, Alessandroni P, Catalano V, Luzi Fedeli S, et al.
Clin Lung Cancer
. 2008 Oct;
9(5):280-4.
PMID: 18824450
Purpose: Paclitaxel and platinum-based chemotherapy is considered to be a standard approach for locally advanced and metastatic non-small-cell lung cancer (NSCLC). In recent years, weekly paclitaxel has been widely used...